BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 10609542)

  • 1. Immunohistochemical finding of alpha-1-antichymotrypsin in tissues of benign prostatic hyperplasia and prostate cancer.
    Tanaka M; Suzuki Y; Takaoka K; Murakami S; Suzuki N; Shimazaki J
    Int J Urol; 1999 Dec; 6(12):600-6. PubMed ID: 10609542
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Alpha 1-antichymotrypsin production in PSA-producing cells is common in prostate cancer but rare in benign prostatic hyperplasia.
    Ansong K
    Urology; 1994 Aug; 44(2):296-7. PubMed ID: 7519383
    [No Abstract]   [Full Text] [Related]  

  • 3. Alpha 1-antichymotrypsin production in PSA-producing cells is common in prostate cancer but rare in benign prostatic hyperplasia.
    Björk T; Bjartell A; Abrahamsson PA; Hulkko S; di Sant'Agnese A; Lilja H
    Urology; 1994 Apr; 43(4):427-34. PubMed ID: 7512295
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunohistochemical evaluation of proliferating cell nuclear antigen, prostate-specific antigen and alpha 1-antichymotrypsin in human prostate cancer.
    Igawa M; Urakami S; Shiina H; Ishibe T; Shirane T; Usui T; Chodak GW
    Br J Urol; 1996 Jan; 77(1):107-12. PubMed ID: 8653279
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prostate-specific antigen and its complexes with alpha 1-antichymotrypsin in the plasma of patients with prostatic disease.
    España F; Martínez M; Sánchez-Cuenca J; Vera CD; Estellés A; Jiménez-Cruz JF
    Eur Urol; 1996; 30(4):512-8. PubMed ID: 8977078
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serum prostate specific antigen complexed to alpha 1-antichymotrypsin as an indicator of prostate cancer.
    Christensson A; Björk T; Nilsson O; Dahlén U; Matikainen MT; Cockett AT; Abrahamsson PA; Lilja H
    J Urol; 1993 Jul; 150(1):100-5. PubMed ID: 7685416
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Free/total prostate-specific antigen ratio--hope and controversies.
    Ravery V; Boccon-Gibod L
    Eur Urol; 1997; 31(4):385-8. PubMed ID: 9187894
    [TBL] [Abstract][Full Text] [Related]  

  • 8. PSA forms complexes with α1-antichymotrypsin in prostate.
    Zhu L; Jäämaa S; Af Hällström TM; Laiho M; Sankila A; Nordling S; Stenman UH; Koistinen H
    Prostate; 2013 Jan; 73(2):219-26. PubMed ID: 22806587
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The proportion of prostate-specific antigen (PSA) complexed to alpha(1)-antichymotrypsin improves the discrimination between prostate cancer and benign prostatic hyperplasia in men with a total PSA of 10 to 30 microg/L.
    Martínez M; España F; Royo M; Alapont JM; Navarro S; Estellés A; Aznar J; Vera CD; Jiménez-Cruz JF
    Clin Chem; 2002 Aug; 48(8):1251-6. PubMed ID: 12142381
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A gap between total prostate-specific antigen and the sum of free prostate-specific antigen plus alpha1-antichymotrypsin-prostate- specific antigen in patients with prostate carcinoma but not in those with benign prostate hyperplasia.
    Jung K; Brux B; Knäbich A; Lein M; Sinha P; Schnorr D; Loening SA
    Clin Chem; 1999 Mar; 45(3):422-4. PubMed ID: 10053050
    [No Abstract]   [Full Text] [Related]  

  • 11. A complex between prostate-specific antigen and alpha 1-antichymotrypsin is the major form of prostate-specific antigen in serum of patients with prostatic cancer: assay of the complex improves clinical sensitivity for cancer.
    Stenman UH; Leinonen J; Alfthan H; Rannikko S; Tuhkanen K; Alfthan O
    Cancer Res; 1991 Jan; 51(1):222-6. PubMed ID: 1703033
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Free and complexed prostate specific antigen in the differentiation of benign prostatic hyperplasia and prostate cancer: studies in serum and plasma samples.
    España F; Royo M; Martínez M; Enguídanos MJ; Vera CD; Estellés A; Aznar J; Jiménez-Cruz JF; Heeb MJ
    J Urol; 1998 Dec; 160(6 Pt 1):2081-8. PubMed ID: 9817329
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Concentrations of free form and complex form of prostate-specific antigen in serum of alpha 2 macroglobulin deficient patients with prostatic carcinoma].
    Kanoh Y; Jimbo S; Shibuya M; Matsuyama N; Mashiko T; Tanaka T; Egawa S; Ohtani H
    Rinsho Byori; 1998 Sep; 46(9):923-9. PubMed ID: 9800478
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prostate specific antigen complexed to alpha-1-antichymotrypsin in patients with intermediate prostate specific antigen levels.
    Saika T; Tsushima T; Nasu Y; Kusaka N; Miyaji Y; Takamoto H; Takeda K; Uno S; Kumon H;
    Cancer; 2002 Mar; 94(6):1685-91. PubMed ID: 11920529
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Determination of alpha1-antichymotrypsin-PSA complex in serum does not improve the differentiation between benign prostatic hyperplasia and prostate cancer compared with total PSA and percent free PSA.
    Jung K; Brux B; Lein M; Knäbich A; Sinha P; Rudolph B; Schnorr D; Loening SA
    Urology; 1999 Jun; 53(6):1160-7; discussion 1167-8. PubMed ID: 10367846
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prostate-specific antigen complexed to alpha(1)-antichymotrypsin in the early detection of prostate cancer.
    Martínez M; España F; Royo M; Vera CD; Estellés A; Jiménez-Cruz JF; Medina P; Aznar J
    Eur Urol; 2000 Jul; 38(1):85-90. PubMed ID: 10859447
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prostate-specific antigen, its molecular forms, and other kallikrein markers for detection of prostate cancer.
    Stephan C; Jung K; Diamandis EP; Rittenhouse HG; Lein M; Loening SA
    Urology; 2002 Jan; 59(1):2-8. PubMed ID: 11796270
    [No Abstract]   [Full Text] [Related]  

  • 18. Measurement of circulating forms of prostate-specific antigen in whole blood immediately after venipuncture: implications for point-of-care testing.
    Piironen T; Nurmi M; Irjala K; Heinonen O; Lilja H; Lövgren T; Pettersson K
    Clin Chem; 2001 Apr; 47(4):703-11. PubMed ID: 11274021
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical evaluation of serum prostate-specific antigen-alpha1-antichymotrypsin complex values in diagnosis of prostate cancer: a cooperative study.
    Kuriyama M; Ueno K; Uno H; Kawada Y; Akimoto S; Noda M; Nasu Y; Tsushima T; Ohmori H; Sakai H; Saito Y; Meguro N; Usami M; Kotake T; Suzuki Y; Arai Y; Shimazaki J
    Int J Urol; 1998 Jan; 5(1):48-54. PubMed ID: 9535601
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Double-label time-resolved immunofluorometric assay of prostate-specific antigen and of its complex with alpha 1-antichymotrypsin.
    Leinonen J; Lövgren T; Vornanen T; Stenman UH
    Clin Chem; 1993 Oct; 39(10):2098-103. PubMed ID: 7691441
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.